Yong S Chang - Ctr Infect & Inflammat Imaging Res, Johns Hopkins Univ

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 26 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Contribution of telacebec to novel drug regimens in a murine tuberculosis model

Oliver D. Komm,Sandeep Tyagi,Andrew Garcia,Deepak Almeida,Yong Chang, Si-Yang Lee,Jennie Ruelas Castillo,Paul J. Converse, Todd Black,Nader Fotouhi,Eric L. Nuermberger

biorxiv（2024）

引用0浏览0引用

Using Dynamic Oral Dosing of Rifapentine and Rifabutin to Simulate Exposure Profiles of Long-Acting Formulations in a Mouse Model of Tuberculosis Preventive Therapy

Yong S. Chang,Si-Yang Li,Henry Pertinez,Fabrice Betoudji,Jin Lee, Steven P. Rannard,Andrew Owen,Eric L. Nuermberger,Nicole C. Ammerman

Antimicrobial agents and chemotherapyno. 7 (2023): e0048123-e0048123

引用0浏览0WOS引用

Supplementary Materials and Methods from Therapeutic Mechanism and Efficacy of the Antibody–Drug Conjugate BAY 79-4620 Targeting Human Carbonic Anhydrase 9

Heike M. Petrul,Christoph A. Schatz,Charlotte C. Kopitz,Lila Adnane,Timothy J. McCabe,Pamela Trail,Sha Ha,Yong S. Chang,Andrei Voznesensky,Gerald Ranges,Paul P. Tamburini

openalex（2023）

引用0浏览0引用

Supplementary Figure 1 from Therapeutic Mechanism and Efficacy of the Antibody–Drug Conjugate BAY 79-4620 Targeting Human Carbonic Anhydrase 9

Heike M. Petrul,Christoph A. Schatz,Charlotte Kopitz,Lila Adnane,Timothy J. McCabe,Pamela A. Trail,Sha Ha,Yong S. Chang,Andrei Voznesensky,Gerald Ranges,Paul P. Tamburini

openalex

引用0浏览0引用

Supplementary Figures 1-4, Tables 1-2 from Dual IGF-I/II–Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth

Jin Gao,Jon W. Chesebrough, Susan A. Cartlidge,Sally-Ann Ricketts,Leonard Incognito,Margaret Veldman-Jones,David C. Blakey,Mohammad Tabrizi,Bahija Jallal,Pamela A. Trail,Steven Coats,Klaus Bosslet,Yong S. Chang

crossref（2023）

引用0浏览0引用

Supplementary Figure 3 from Therapeutic Mechanism and Efficacy of the Antibody–Drug Conjugate BAY 79-4620 Targeting Human Carbonic Anhydrase 9

Heike M. Petrul,Christoph A. Schatz,Charlotte Kopitz,Lila Adnane,Timothy J. McCabe,Pamela A. Trail,Sha Ha,Yong S. Chang,Andrei Voznesensky,Gerald Ranges,Paul P. Tamburini

openalex（2023）

引用0浏览0引用

Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized Α-Helical Peptide in Clinical Development

Vincent Guerlavais,Tomi K. Sawyer,Luis Carvajal,Yong S. Chang,Bradford Graves,Jian-Guo Ren,David Sutton,Karen A. Olson,Kathryn Packman,Krzysztof Darlak,Carl Elkin,Eric Feyfant,Kamala Kesavan,Pranoti Gangurde,Lyubomir T. Vassilev,Huw M. Nash,Vojislav Vukovic,Manuel Aivado,D. Allen Annis

JOURNAL OF MEDICINAL CHEMISTRYno. 14 (2023): 9401-9417

引用0浏览0WOS引用

Supplementary Table 2 from Therapeutic Mechanism and Efficacy of the Antibody–Drug Conjugate BAY 79-4620 Targeting Human Carbonic Anhydrase 9

Heike M. Petrul,Christoph A. Schatz,Charlotte Kopitz,Lila Adnane,Timothy J. McCabe, Pamela A. Trail,Sha Ha,Yong S. Chang,Andrei Voznesensky,Gerald Ranges,Paul P. Tamburini

openalex（2023）

引用0浏览0引用

Lysyl-tRNA Synthetase, a Target for Urgently Needed M. Tuberculosis Drugs

Nature Communications（2022）

引用42浏览0WOSNATURE引用

Preserved Efficacy and Reduced Toxicity with Intermittent Linezolid Dosing in Combination with Bedaquiline and Pretomanid in a Murine TB Model

Kristina M. Bigelow,Rokeya Tasneen,Yong S. Chang,Kelly E. Dooley,Eric L. Nuermberger

bioRxiv（2020）

引用18浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn